OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-12-31-accounts

CONTENTS
ChairofTrustee'sStatement 2
ChiefExecutive'sStatement 3
TrusteesReport
AboutHMT 5
Ourstrategy,charitablemission,visionandpurpose 8
Ourvalues 9
Buildingourbrandandgrowingourbusiness 10
Organisationalpriorities 11
OurCare 12
Patientandresidentengagement 15
Ourpeople 17
Technology 25
Environmentandsustainability 27
Engagementwithkeystakeholders-keydecisions 32
Financialreview 37
Structure,governanceandmanagement 40
Trusteebiographies 43
Attendanceatboardmeetings 48
Trusteeremuneration,conflictsofinterestandstatementofadherencetothe
fundraisingregulatorcode 54
Trustees'responsibilitystatement 55
Independentauditor'sreport 56
Statementoffinancialactivities 61
Balancesheet 62
Statementofcashflows 63
Notetotheaccounts 70
Referenceandadministrationdetails 84

TRUSTEES, REPORT INCLUDING SECTION 172 STATEMENT AND STRATEGIC REPORT

ColomaCourt MarieLouise
House
StHugh's SanctaMaria
Overallcurrent
CQC/HIW
Rating
Outstanding Good Requires
Improvement
HIW
LastFocused
Inspection
Date
04/08/2020 31/01/2022 05/03/2019 AwaitingHIW
report(asat31
December
2023)*
Reviewof
data
Nilconcernraised Nilconcerns
raised
Nooutstanding
concerns.
Nooutstanding
concerns.
Received9th Received11th
PIR-
Requests
February
2023Submitted
January
2023Submitted
N/A N/A
date22/02/2023 08/02/23

FY23 FY22 %change
Energy(kWh)
Naturalgas 3,058,236 3,337,250 -8.4%
Companyvehicles 13,904 10,388 34.5%
Electricity 2,034,183 2,056,311 -1.1%
Businesstravel 57,066 78,351 -27.2%
Totalenergy 5,163,389 5,482,300 -5.8%
Emissions(tCO2e)
Scope1 Naturalgas 559.4 609.2 -8.2%
Scope1 Companyvehicles 3.3 2.8 25.0%
Scope2 Electricity(LB) 421.2 397.6 5.9%
Scope3 Businesstravel 13.8 19.3 -28.5%
TotalSECR
emissions
997.7 1,028.9 -3.0%
Emissionintensity
ratio
Full-timeemployee 465 465 0.0%
Emissionsintensity
(tCO2e/Full-time
employee)
2.146 2.213 -3.0%

S172 SpecificExamplescoveredinthisreport
(a)thelikelyconsequencesofany DevelopmentofnewStrategy
decisioninthelongterm Significantinvestmentinnewsystems
Overseasrecruitment
(b)theinterestsofthecompany's PayawardCostofLivingPayment
employees LearningandDevelopment
SpeakingUpCommunicationwithcolleagues
(c)theneedtofosterthe Residentandpatientfeedback
company'sbusinessrelationships Regularmeetingswithsuppliers
withsuppliers,customersand EnsuringHMTengagesinthefutureshapeofhealthandsocialcare
others; serviceprovision
(d)theimpactofthecompany's
operationsonthecommunityand
theenvironment
AppointmentofNetZeroLead
Sustainabledevelopmentofnewservices
(e)thedesirabilityofthecompany
maintainingareputationforhigh CareQualityCommissionandHIWComplianceratings
standardsofbusinessconduct
(f)theneedtoactfairlybetween
membersofthecompany
ReviewandchangeofGovernanceStructure

Risk DescriptionandPotentialImpact Keycontrolsandmitigatingfactors
Inordertoensureweareattractiveina
Recruitment Thereisanationalshortageofhealthandsocialcare
workers.Thereisariskthatwewillbeabletocontinueto
attractsuitabilitytrainedstaff,particularlyinspecialistareas.
Thiscouldleadtogreaterrelianceuponagencystaff,impacting
financialperformanceandcontinuousqualitypatientand
residentcare.
highlycompetitivemarket;weregularly
reviewourpayandbenefitsframeworkto
ensureweareofferingafairand
competitivepackage.Weinvestinour
colleaguesintraininganddevelopment.
Wecontinuetoreviewourwellbeing
programmeofferedtostaff.Wehave
widenedrecruitmenttooverseas.
Estateand
property
Thereisaneedforcontinuedsignificantinvestmentand
maintenance/remedialworktoHMT'spropertyandunderlease
repairingobligations.Theadversefinancialpositioninprevious
yearshascauseddelaystothecapitalexpenditureprogramme
ofwork.
Surveyforallsiteshavebeenobtained
andtheextentoftheworksareknown.
The2024budgethasprovisionforyear1
ofsuchworks.
Increasedcosts
andinflationary
pressures
Theannualrateofinflationreached11.1%inOctober2022,a
41-yearhigh,beforesubsequentlyeasing.Highinflationaffects
theaffordabilityofgoodsandservices,notonlyforHMTbut
alsoforourservicesusers.WhilsttheUK'sannualinflationrate
fellin2023itisstillhigh.
Weensurethatweworkcloselywith
supplierstoensurethatthebestratesare
achieved.Wecontinuouslylookfor
efficienciesinprocesses.
Activityand
Occupancy
Thereisacontinuingchallengeoftheeconomicclimateandits
impactonHMT'spatientsandresidents'abilitytoself-fund
treatmentandcareatitshospitalsandcarehomes,resultingin
budgetedactivityandoccupancylevelsnotbeingachieved.
Wecontinuetomarketand
communicationtheservicesofferedby
HMTandworkcloselywithpartners,such
astheNHSandlocalauthorities.
Efficiencyplanningisalwaysconsidered.
CQC/HIW Failureforourservicestomaintain/achievegoodor Siteshaveactionplansinplacetoensure
Ratingand outstandingcompliancewiththeCQC/HIWcouldleadto complianceandcontinuousquality
compliance financiallossesandreputationaldamage. improvement.
HMTattemptstomitigatetheserisks
Government
Policy
Thefundingforhealthandsocialcareisthegovernment's
responsibility.HMThassignificantcontractsandframework
agreementsinplacewiththeNHS.TheNHStariffincreases
generallyhavebeenbelowthegeneralinflationrateandwe
haveseenourmarginonNHSworkeroded.Otherrisks
includeNationalMinimumWage,Brexit,theGovernment's
approachtohealthandsocialcare.
throughtheregularreviewofstrategyto
ensurethatwecanbeflexibletotake
accountofexternalconditions.Weare
workcloselywithlocalcommissionersand
throughtheIndependentHealthcare
ProvidersNetworkandtheNationalCare
Forumonanationallevel,toendeavour
toaddressthesechallengesandinform
thereformagenda.
Compliance Failuretocomplywithlegislationandregulationcouldleadto Weensurecompliancethroughpolicies
withlegislation financialloss,reputationaldamage,claimsagainstHMT, andprocedures,riskassessments,internal
andregulation prosecution,andlossofregistration. audits,insurance,andtraining.
Thereareanumberofpoliciesinplace
Majorincident Aseriousincidentresultinginavoidableharm,resultingin
seriousinjuryordeathtoapatient,resident,oremployee.
andmonitoringofhealthandsafety
requirements.ClinicalGovernanceand
Qualitymanagementisahighpriorityand
robustlymonitored.

Trustee Originallyappointed Re-appointed
DJones 12/12/2012 26/07/2023
MGerold 16/09/2015 27/07/2022
GvonMalachowski 20/04/2016 26/07/2023
CFryar 25/05/2022*
LGeary 25/05/2022
JSanders 25/05/2022
MShenouda 26/07/2023
MBriggs 27/09/2023**

13.02.2023 13.05.2023 12.07.2023 29.11.2023
DJones 
JSanders    
MGerold    
GvonMalachowski    
LGeary X X  

13.04.2023 12.10.2023
LDinner 
LRoberts 
GvonMalachowski  
CFryar X 
MBriggs V
MShenouda V

27.09.23
DJones V
MGerold V
GvonMalachowski V
CFryar V
LGeary V
JSanders V
NDraper V
MShenouda V

03 June 2024

StatementofFinancialactivities
FORTHEYEARENDED31DECEMBER2023 Notes Totalfunds
2023
Totalfunds
2022
£ £
INCOMEANDEXPENDITUREACCOUNT
INCOMEFROM:
Donationsandlegacies 31,494 730
Investmentincomeandinterestreceivable 1 67,151 7,009
Charitableactivities
.Healthcareestablishmentfeesandrelatedcharges 2 50,460,543 45,553,965
Totalincome 50,559,188 45,561,704
EXPENDITUREON:
Raisingfunds
Investmentmanager'sfees 4,179
Financingcosts 3 530,938 473,452
530,938 477,631
Charitableactivities
Promotionanddevelopmentofhealthcare
.Healthcareestablishmentexpenses 4 47,835,857 46,747,143
.Charitablegrants 5 188,553 47,045
48,024,410 46,794,188
Totalexpenditure 48,555,348 47,271,819
Netincome(expenditure)beforelossesoninvestments 7 2,003,840 (1,710,115)
Net(losses)onlistedinvestments(fullyliquidatedin2022) (41,040)
Netincome(expenditure)fortheyearandnetmovementinfunds 2,003,840 (1,751,155)
Reconciliationoffunds:
Balancesbroughtforwardat1January2023 18,994,063 20,745,218
Balancescarriedforwardat31December2023 20,997,902 18,994,063

BALANCESHEET
FORTHEYEARENDED31DECEMBER2023 Notes 2023
£
2022
£
Fixedassets
Tangiblefixedassets 10 30,733,509 30,724,348
30,733,509 30,724,348
Currentassets
Stocks 11 556,715 562,042
Debtors 12 2,606,568 2,500,374
Cashatbankandinhand 6,200,509 3,605,296
9,363,792 6,667,712
Creditors:amountsfallingduewithinoneyear: 13 (8,644,883) (7,029.539)
Netcurrentassets(liabilities) 718,909 (361,827)
Totalassetslesscurrentliabilities 31,452,418 30,362,521
Creditors:amountsfallingdueafteroneyear 14 (10,454,516) (11,368,458)
Totalnetassets 20,997,902 18,994,063
ThefundsoftheTrust
Generalfunds 1,361,442 428,393
Tangiblefixedassetsfund 15 19,214,849 18,290,549
Designatedfunds 16 421,611 275,121
20,997,902 18,994,063

2023 2022
Notes
£
£
Cashflowsfromoperatingactivities:
Netcashprovidedby(usedin)operatingactivities A 6,121,036 (596,444)
Cashflowsfrominvestingactivities:
Investmentincomeandinterestreceived 67,151 7,009
Purchaseoftangiblefixedassets (2,148,094) (891,591)
Proceedsfromdisposaloffixedassets 800,000
Proceedsfromthedisposalofinvestments 1,535,290
Netcash(usedin)providedbyinvestingactivities (2,080,943) 1,450,708
Cashflowsfromfinancingactivities:
Interestpaid (530,938) (473,452)
Repaymentsofborrowing (575,000) (575,000)
Repaymentsoffinanceleases (338,942) (489,204)
Netcash(usedin)financingactivities (1,444,880) (1,537,656)
Changeincashandcashequivalentsintheyear 2,595,213 (683,391)
Cashandcashequivalentsat1January2023 B 3,605,296 4,288,687
Cashandcashequivalentsat31December2023 B 6,200,509 3,605,296

2023 2022
Netmovementinfunds(asperthestatementoffinancialactivities) 2,003,840 (1,751,155)
Adjustmentsfor:
Depreciationcharge 2,076,117 2,108,642
Lossesoninvestments 41,040
Investmentincomeandinterestreceivable (67,151) (7,009)
Interestpayable 530,938 473,452
Lossondisposaloftangiblefixedassets 62,815 201,124
Decreaseinstocks 5,327 6,341
(Increase)decreaseindebtors (106,194) 805,381
Increase(decrease)increditors 1,615,344 (2,474.260)
Netcashprovidedby(usedin)operatingactivities 6,121,036 (596,444)
BAnalysisofcashandcashequivalents 2023 2022
Cashatbankandinhand 6,200,509 3,605,296
Totalcashandcashequivalents 6,200,509 3,605,296
CAnalysisofchangesinnetdebt At1January
2023
£'000
Cash
flows
£'000
Other
non-cash
changes
£'000
At31
December
2023
£'000
Cash 3,605,296 2,595,213 1,010,083
Financeleaseobligations (1,508,798) 340,138 1,168,660
Loans (10,925,000) 575,000 11,500,000
Total (8,828,502) 3,510,351 11,658,577

1.Investmentincomeandinterestreceivable Unrestricted funds
2023 2022
£ £
Incomefromlistedinvestments 5,957
Interestreceivable 67,151 1,052
67,151 7,009
2.Healthcareestablishmentfeesandrelatedcharges Unrestrict edfunds
2023 2022
£ £
Managementandconsultancyfees 99,866 60,014
Hospitalfeesandrelatedcharges 40,996,502 37,873,903
Nursingandresidentialhomefeesandrelatedcharges 9,364,175 7,620,048
50,460,543 45,553,965
3.Financingcosts Unrestricted funds
2023 2022
£ £
Interestpayableonbankloansandfinanceleases 530,938 473,452

2023 2022
£ £
Staffcosts(note8) 19,331,010 18,625,944
Premisesandequipment 6,532,729 6,208,334
Medicalandwelfare 18,565,394 17,740,495
Governancecosts(note6) 62,743 91,360
Otherexpenses 3,343,982 4,081,011
47,835,858 46,747,143

2023 2022
£ £
Charitabledonationsandshareofsurplus(note 18) 188,553 47,045

2023 2022
£ £
Internalaudit - 12,808
Externalaudit,committeeandothercosts 62,743 78,552
62,743 91,360
7.Netincome(expenditure)beforelossesoninvestments Unrestrictedfunds Unrestrictedfunds
Thisisstatedaftercharging: 2023 2022
Staffcosts(note8) 19,331,010 18,625,944
Externalauditor'sremuneration
Auditservices(includingVAT) 41,267 41,375
Depreciation 2,076,117 2,108,642
Operatingleaserentals 577,340 489,503
Hireofplantandmachinery
Rentalofnon-medicalequipment 165,436 90,878
Rentalofmedicalequipment 1,459,367 1,022,599
8.StaffcostsandTrustees'remuneration
2023 2022
£ £
Staffcostsduringtheyearwereasfollows:
Wagesandsalaries 16,222,062 14,892,405
Socialsecuritycosts 1,547,043 1,445,569
Otherpensioncosts 565,882 510,903
Apprenticeshiplevy 68,438 58,794
Paymentstoemployedstaff 18,403,425 16,907,670
Paymentstoagencystaff 927,585 1,718,274
19,331,010 18,625,944
Full timeequivalents Headcount
2023
2022
2023 2022
Healthcareservices 492 465 627 594

2023 2022
£60,001-£70,000 9 6
£70,001-£80,000 8* 3
£80,001-£90,000 2 2
£90,001-£100,000 1 1*
£100,001-£110,000 1
£110,001-£120,000 1
£130,001-£140,000 1
£140,001-£150,000 1
£150,001-£160,000 1
£160,001-£170,000 1* 2*
£190,001-£200,000 1 1*
£280,001-£290,000 1*

Freehold
property
Leasehold
property
Fixturesand
fittings
Plantand
equipment
Total
Costorvaluation
At1January2023 4,041,153 22,126,323 4,324,933 15,456,045 45,948,454
Additions 122,605 519,557 487,446 1,018,486 2,148,094
Disposals (492,419) (1,436,896) (1,929,315)
At31December2023 4,163,758 22,645,880 4,319,960 15,037,635 46,167,2333
Cost 2,913,758 22,645,880 4,319,960 15,037,635 44,917,233
Deemedcost:Valuation
-1990
1,250,000 1,250,000
4,163,758 22,645,880 4,319,960 15,037,635 46,917,233
Depreciation
At1January2023 1,141,193 585,650 2,503,860 10,993,403 15,224,106
Providedintheyear 73,349 385,119 396,501 1,221,148 2,076,117
Reclassification 19,471 (19,471)
Ondisposals (277,695) (1,588,805) (1,866,500)
At31December2023 1,214,542 990,240 2,603,195 10,625,746 15,433,723
Netbookvalues
At31December2023 2,949,216 21,655,640 1,716,765 4,411,889 30,733,510
At31December2022 2,899,960 21,540,673 1,821,075 4,462,640 30,724,348

Cost 1,023,209
Accumulateddepreciation (758,842)
Netbookamountat31December2023 264,367
Netbookvalueat31December2022 289,847

11.Stocks
2023 2022
£ £
Drugs,dressingsandconsumables 556,715 562,042
12.Debtors
2023 2022
£ £
Feesandrelatedcharges 1,498,147 1,467,457
Otherdebtors 3,247 6,558
Prepaymentsandaccruedincome 1,105,174 1,026,359
2,606,568 2,500,375

2023 2022
£ £
Expensecreditors 2,745,036 2,718,009
Socialsecurityandothertaxes 556,164 373,310
Othercreditors 45,046 30,285
Accrualsanddeferredincome 3,316,959 2,255,794
SanctaMariaconstructioncreditors 586,800 586,800
Financeleaserepayablewithinoneyear 489,144 490,341
Bankloanrepayablewithinoneyear 575,000 575,000
8,644,883 7,029,539

14.Creditors:amountsfallingdueafteroneyear
2023 2022
£ £
Financeleaserepayable(seebelow) 679,516 1,018,458
Bankloan(seebelow) 9,775,000 10,350,000
10,454,516 11,368,458

Financelease
2023 2022
Amountsdue:
Withinoneyear(note13) 489,144 490,341
Betweenoneandtwoyears 144,233 483,165
Betweentwoandfiveyears 535,293 535,293
679,516 1,018,458
1,168,660 1,508,799
2023 2022
Amountsdue:
Withinoneyear(note14) 575,000 575,000
Betweenoneandtwoyears 575,000 575,000
Betweentwoandfiveyears 1,725,000 1,725,000
Betweenfiveandsevenyears 7,475,000 8,050,000
9,775,000 10,350,000
10,350,000 10,925,000

15.Tangiblefixedassetsfund
Total Total
2023 2022
£ £
At1January2023 30,724,348 32,942,525
Netmovementintheyear 9,161 (2,218,177)
30,733,509 30,724,348
Less:Bankloanandfinanceleasestofinancetheconstructionand
acquisitionoftangiblefixedassets
(11,518,660) (12,433,799)
At31December2023 19,214,849 18,290,549

At1
January
2023
New
designations
Released
or
utilised
At31
December
2023
£ £
MarieLouiseHousebuildingand
equipmentreserve
3,144 6,489 9,633
ColomaCourtbuildingreserve 271,977 140,000 411,978
275,121 146,489 421,611
At1
January
2022
New
designations
Released
or
utilised
At31
December
2022
£ £
MarieLouiseHousebuildingand
equipmentreserve
3,144 3,144
ColomaCourtbuildingreserve 271,977 271,977
275,121 275,121

General
funds
Tangiblefixed
assets
fund
Designated
funds
£
Total
2023
£
Tangiblefixedassets 30,733,509 - 30,733,509
Netcurrentassets 1,361,440 (1,064,144) 421,611 718,907
Creditors:Amountsfallingdueafter
oneyear
- (10,454,516) - (10,454,516)
1,361,440 19,214,849 421,611 20,997,901
General
funds
Tangiblefixed
assets
fund
Designated
funds
£
Total
2022
£
Tangiblefixedassets 30,724,348 30,724,348
Netcurrentassets 428,393 (1,065,341) 275,121 (361,827)
Creditors:Amountsfallingdueafter
oneyear
(11,368,458) (11,368,458)
428,393 18,290,549 275,121 18,994,063
theCompaniesAct2006.Movementsinunrealisedgainsduringthe yearwereasfollo ws:
2023 2022
Unrealisedgainsincludedabove:
Onfreeholdproperty 69,870 64,200
Totalunrealisedgainsat31December2023 69,870 64,200
Reconciliationofmovementsinunrealisedgains
Unrealisedgainsat1January2023 64,200 203,087
Differencebetweenhistoricalcostrealisedgains/lossesonlisted
investmentsandtheactualrealisedgains/lossesthereoncalculated (144,557)
ontherevaluedamounts
Differencebetweenthedepreciationchargebasedonhistoriccost
andthatbasedontherevaluedamounts
5,670 5,670
Totalunrealisedgainsat31December2023 69,870 64,200
80
HealthcareManagementTrust

Landand buildings Other
2023 2022 2023 2022
£ £ £ £
Operatingleaseswhichexpire:
Withinoneyear 813,808 505,245 69,502 72,095
Withintwotofiveyears 3,237,938 1,087,608 43,636 118,365
Over5years 19,520,000
23,571,746 1,592,853 113,138 190,460

Company number 01932882

I

*HMT HEALTHCARE MANAGEMENT TRUST